ADVIKLA

MPS Pharma Share Price

₹2.76 +0.13 (4.94%)

23 May, 2025 02:02

SIP TrendupStart SIP in ADVIKLA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month -8%
  • Over 3 Month -30.83%
  • Over 6 Month -33.17%
  • Over 1 Year -17.12%
SIP Lightning

Smart Investing Starts Here Start SIP with MPS Pharma for Steady Growth!

Invest Now

MPS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

MPS Pharma Financials

MPS Pharma Technicals

EMA & SMA

Current Price
₹2.76
+ 0.13 (4.94%)
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹3.28
  • 50 Day
  • ₹3.43
  • 100 Day
  • ₹3.12
  • 200 Day
  • ₹2.61

Resistance and Support

2.67 Pivot Speed
  • R3 3.11
  • R2 2.93
  • R1 2.85
  • S1 2.59
  • S2 2.41
  • S3 2.33

What's your outlook on MPS Pharma?

You can only vote once!

MPS Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-28 Audited Results
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results
2024-08-13 Quarterly Results
2024-05-30 Audited Results

MPS Pharma F&O

MPS Pharma Shareholding Pattern

No data available.

About MPS Pharma

  • NSE Symbol
  • ADVIKLA
  • BSE Symbol
  • 531686
  • ISIN
  • INE537C01019

Similar Stocks to MPS Pharma

MPS Pharma FAQs

MPS Pharma share price is ₹2 As on 23 May, 2025 | 01:48

The Market Cap of MPS Pharma is ₹5.3 Cr As on 23 May, 2025 | 01:48

The P/E ratio of MPS Pharma is -6.1 As on 23 May, 2025 | 01:48

The PB ratio of MPS Pharma is 2.7 As on 23 May, 2025 | 01:48

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23